A Study to Measure the Amount of Evacetrapib That Enters the Blood Stream in Healthy Participants

Summary

Evacetrapib (study drug) is an investigational drug being developed with the aim to help people at high risk of heart problems in the future. In this study we will be comparing how much of the study drug gets into the blood stream when it is given as a single dose (in tablet form) compared to an intravenous injection (given directly into a vein via a small needle). The study is expected to last at least 15 days for each participant, not including screening. Screening will occur up to 28 days before the study drug is given.

Timeline

Start

2014-10

Primary completion

2014-11

Completion

2014-11

Drugs

Indications

No indication recorded.